Related Experiment Video
Updated: May 8, 2026

05:03
Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy
Published on: April 17, 2020
Is brain death diagnosis in newborns feasible?
I Chatziioannidis1, P Chouchou, N Nikolaidis
1Neonatal Intensive Care Unit A.U.T, GPN "Papageorgiou", Thessaloniki.
Hippokratia
|August 13, 2013
Summary
Diagnosing brain death (BD) in newborns requires extreme caution due to unique brain function differences. Guidelines emphasize longer observation periods and expert physician confirmation for irreversible loss of brain function.
Area of Science:
- Neurology
- Pediatrics
- Critical Care Medicine
Background:
- Brain death (BD) involves irreversible loss of all brain functions, including the brainstem.
- It is an uncommon but critical outcome in newborns requiring life support, often resulting from severe central nervous system insults.
- Common causes in children include asphyxia, intracranial hemorrhage, and infection.
Purpose of the Study:
- To present current guidelines for determining brain death in the neonatal population.
- To discuss the application of these guidelines in Greece.
- To highlight the necessary caution due to age-specific neurological differences.
Main Methods:
- Diagnosis of brain death relies on clinical criteria.
- Establishing brain death in newborns necessitates longer observational periods (minimum 24 hours apart) compared to adults.
- Confirmation requires assessment by at least two expert physicians.
Main Results:
- Neonatal brain death diagnosis requires adherence to specific, cautious protocols.
- Established guidelines aim to ensure the accurate determination of irreversible loss of brain function.
- Expert consensus and prolonged observation are critical components.
Conclusions:
- Brain death determination in newborns is complex and demands meticulous application of current guidelines.
- Specific neurodiagnostic tests and extended observation periods are crucial for accurate diagnosis.
- The guidelines presented are intended for application in clinical practice, particularly in regions like Greece.
